Macrophage migration inhibitory factor is elevated in obese adolescents

Archives of Physiology and Biochemistry

Volumn 118, Issue 4, 2012, Pages 204-209

  Kamchybekov, Uran ^a   Figulla, Hans R ^a   Gerdes, Norbert ^b,c   Jung, Christian ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Adolescents; BMI; Macrophage migration inhibitory factor; Overweight; Waist circumference

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR;

ABDOMINAL OBESITY; ADOLESCENT; ARTICLE; BLOOD; BLOOD PRESSURE; HUMAN; MALE; METABOLISM; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; HUMANS; LINEAR MODELS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; OBESITY, ABDOMINAL;

EID: 84865472372     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2012.693089     Document Type: Article

References (29)

1. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, et al. (2007). MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587-96.
2. Bosy-Westphal A, Booke CA, Blocker T, Kossel E, Goele K, Later W, Hitze B, Heller M, Gluer CC, Muller MJ. (2010). Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population. J Nutr 140:954-61.
3. Church TS, Willis MS, Priest EL, Lamonte MJ, Earnest CP, Wilkinson WJ, Wilson DA, Giroir BP. (2005). Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 29:675-81.
4. Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A. (2004). Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89:5043-7.
5. Despres JP, Lemieux I. (2006). Abdominal obesity and metabolic syndrome. Nature 444:881-7.
6. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P. (2008). Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039-49.
7. Dewor M, Steffens G, Krohn R, Weber C, Baron J, Bernhagen J. (2007). Macrophage migration inhibitory factor (MIF) promotes fibroblast migration in scratch-wounded monolayers in vitro. FEBS Lett 581:4734-42.
8. Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, et al. (2000). Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136:664-72.
9. Flegal KM, Carroll MD, Ogden CL, Curtin LR. (2010). Prevalence and trends in obesity among US adults. 1999-2008. Jama 303:235-41.
10. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. (1999). The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 103:1175-82.
11. Herder C, Klopp N, Baumert J, Muller M, Khuseyinova N, Meisinger C, Martin S, Illig T, Koenig W, Thorand B. (2008). Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study. 1984-2002. Diabetologia 51:276-84.
12. Jung C, Fischer N, Fritzenwanger M, Figulla HR. (2010a). Anthropometric indices as predictors of the metabolic syndrome and its components in adolescents. Pediatr Int 52:402-9.
13. Jung C, Fischer N, Fritzenwanger M, Pernow J, Brehm BR, Figulla HR. (2009a). Association of waist circumference, traditional cardiovascular risk factors, and stromal-derived factor-1 in adolescents. Pediatr Diabetes 10:329-35.
14. Jung C, Fischer N, Fritzenwanger M, Thude H, Ferrari M, Fabris M, Brehm BR, Barz D, Figulla HR. (2009b). Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age. Clin Res Cardiol 98:179-88.
15. Jung C, Gerdes N, Fritzenwanger M, Figulla HR. (2010b). Circulating levels of interleukin-1 family cytokines in overweight adolescents. Mediators Inflamm 2010:958403.
16. Jung C, Rafnsson A, Shemyakin A, Bohm F, Pernow J. (2010c). Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int J Cardiol 3:368-72.
17. Kleemann R, Bucala R. (2010). Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm 2010:610479.
18. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Gei HC, Hesse V, Von Hippel A, Jaeger U, Johnsen D, Korte W, et al. (2001). Perzentile f den Body-mass-Index f das Kindesund Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift Kinderheilkunde 149:807-18.
19. Murdolo G, Nowotny B, Celi F, Donati M, Bini V, Papi F, Gornitzka G, Castellani S, Roden M, Falorni A, Herder C. (2011). Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren. PLoS One 6:e17264.
20. Nishihira J. (2000). Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res 20:751-62.
21. Pausova Z, Mahboubi A, Abrahamowicz M, Leonard GT, Perron M, Richer L, Veillette S, Gaudet D, Paus, T. (2012). Sex differences in the contributions of visceral and total body fat to blood pressure in adolescence. Hypertension 59:572-9.
22. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. (2003). Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138:24-32.
23. Reilly JJ. (2006). Obesity in childhood and adolescence: evidence based clinical and public health perspectives. Postgrad Med J 82:429-37.
24. Serre-Beinier V, Toso C, Morel P, Gonelle-Gispert C, Veyrat-Durebex C, Rohner-Jeanrenaud F, Calandra T, Roger T, James RW, Montet X, et al. (2010). Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice. J Endocrinol 206:297-306.
25. Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb, H. (2005). Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146:1006-11.
26. Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, Van Erk M, De Vries-Van Der Weij J, Leng L, Van Bockel JH, Van Dijk KW, et al. (2009). MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105:99-107.
27. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-30.
28. Ye J, Gao Z, Yin J, He Q. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118-28.
29. Zernecke A, Bernhagen J, Weber C. (2008). Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117:1594-602.